Larry Todd Edwards's most recent trade in Arcutis Biotherapeutics Inc was a trade of 7,451 Common Stock done at an average price of $14.1 . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Sale of securities on an exchange or to another person at price $ 14.07 per share. | 19 May 2025 | 7,451 | 183,104 (0%) | 0% | 14.1 | 104,850 | Common Stock |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99,000 | 99,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 43,000 | 43,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 38,000 | 173,555 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 17,000 | 190,555 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 03 Feb 2025 | 2,173 | 135,555 (0%) | 0% | 12.7 | 27,597 | Common Stock |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Purchase of securities on an exchange or from another person at price $ 7.11 per share. | 30 Nov 2024 | 1,093 | 137,728 (0%) | 0% | 7.1 | 7,767 | Common Stock |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 02 Oct 2024 | 3,725 | 136,635 (0%) | 0% | 10.0 | 37,295 | Common Stock |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | SVP Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 60,000 | 148,000 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.98 per share. | 16 May 2024 | 7,640 | 140,360 (0%) | 0% | 9.0 | 68,582 | Common Stock |
| Arcutis Biotherapeutics Inc | Todd Edwards Larry | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 176,000 | 176,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Todd Edwards Larry | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 28,000 | 88,000 (0%) | 0% | 0 | Common Stock |